Destination Wealth Management Abbott Laboratories Transaction History

Destination Wealth Management

$3 Billion
Q2 2024

A detailed history of Destination Wealth Management transactions in Abbott Laboratories stock. As of the latest transaction made, Destination Wealth Management holds 237,259 shares of ABT stock, worth $27.5 Million. This represents 0.82% of its overall portfolio holdings.

Number of Shares

237,259

Previous 234,943 0.99%

Holding current value

$27.5 Million

Previous $26.7 Million 7.68%

% of portfolio

0.82%

Previous 0.9%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	BUY	$100.73 - $112.44 $233,290 - $260,411	2,316 Added 0.99%	237,259 $24.7 Million
Q1 2024 May 14, 2024	BUY	$109.52 - $120.96 $198,888 - $219,663	1,816 Added 0.78%	234,943 $26.7 Million
Q4 2023 Feb 13, 2024	SELL	$90.19 - $110.4 $231,788 - $283,728	-2,570 Reduced 1.09%	233,127 $25.7 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $404,187 - $484,957	4,231 Added 1.83%	235,697 $22.8 Million
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $69,840 - $77,816	-693 Reduced 0.3%	231,466 $25.2 Million
Q1 2023 May 05, 2023	BUY	$96.86 - $114.01 $349,083 - $410,892	3,604 Added 1.58%	232,159 $23.5 Million
Q4 2022 Feb 10, 2023	SELL	$95.06 - $111.52 $254,475 - $298,539	-2,677 Reduced 1.16%	228,555 $25.1 Million
Q3 2022 Nov 10, 2022	BUY	$96.76 - $112.03 $236,094 - $273,353	2,440 Added 1.07%	231,232 $22.4 Million
Q2 2022 Jul 29, 2022	BUY	$102.07 - $123.37 $111,562 - $134,843	1,093 Added 0.48%	228,792 $24.9 Million
Q1 2022 May 12, 2022	BUY	$114.02 - $139.04 $231,916 - $282,807	2,034 Added 0.9%	227,699 $27 Million
Q4 2021 Feb 04, 2022	BUY	$115.53 - $141.46 $293,908 - $359,874	2,544 Added 1.14%	225,665 $31.8 Million
Q3 2021 Oct 25, 2021	SELL	$116.66 - $129.06 $10,499 - $11,615	-90 Reduced 0.04%	223,121 $26.4 Million
Q2 2021 Aug 13, 2021	BUY	$105.79 - $124.53 $111,820 - $131,628	1,057 Added 0.48%	223,211 $25.9 Million
Q1 2021 May 05, 2021	SELL	$108.84 - $128.23 $295,609 - $348,272	-2,716 Reduced 1.21%	222,154 $26.6 Million
Q4 2020 Feb 11, 2021	BUY	$105.0 - $114.42 $63,630 - $69,338	606 Added 0.27%	224,870 $24.6 Million
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $761,070 - $924,263	-8,305 Reduced 3.57%	224,264 $24.4 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $83,308 - $106,624	1,088 Added 0.47%	232,569 $21.3 Million
Q1 2020 May 13, 2020	SELL	$62.82 - $91.86 $60,621 - $88,644	-965 Reduced 0.42%	231,481 $18.3 Million
Q4 2019 Feb 12, 2020	SELL	$78.51 - $87.4 $163,693 - $182,229	-2,085 Reduced 0.89%	232,446 $20.2 Million
Q3 2019 Nov 13, 2019	SELL	$81.84 - $88.74 $240,364 - $260,629	-2,937 Reduced 1.24%	234,531 $19.6 Million
Q2 2019 Jul 19, 2019	SELL	$72.88 - $85.0 $736,743 - $859,265	-10,109 Reduced 4.08%	237,468 $20 Million
Q1 2019 May 01, 2019	SELL	$66.22 - $80.06 $612,270 - $740,234	-9,246 Reduced 3.6%	247,577 $19.8 Million
Q4 2018 Feb 05, 2019	BUY	$65.56 - $74.27 $496,485 - $562,446	7,573 Added 3.04%	256,823 $18.6 Million
Q3 2018 Nov 07, 2018	BUY	$60.81 - $73.36 $1.94 Million - $2.34 Million	31,841 Added 14.65%	249,250 $18.3 Million
Q2 2018 Jul 31, 2018	SELL	$57.57 - $63.54 $440,468 - $486,144	-7,651 Reduced 3.4%	217,409 $13.3 Million
Q1 2018 Apr 05, 2018	SELL	$56.27 - $63.62 $768,254 - $868,603	-13,653 Reduced 5.72%	225,060 $13.5 Million
Q4 2017 Feb 09, 2018	SELL	$53.68 - $57.47 $490,527 - $525,160	-9,138 Reduced 3.69%	238,713 $13.6 Million
Q3 2017 Nov 09, 2017	SELL	$48.06 - $53.64 $400,724 - $447,250	-8,338 Reduced 3.25%	247,851 $13.2 Million
Q2 2017 Aug 11, 2017	BUY	N/A	256,189	256,189 $12.5 Million

Others Institutions Holding ABT

# of Institutions

3,184

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Destination Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Destination Wealth Management with notifications on news.

Account

Destination Wealth Management Abbott Laboratories Transaction History